Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe Read more
Novo Holdings Repair Impact Fund supports MinervaX EUR 72 million financing to develop vaccine against Group B Streptococcus Read more